Clinical Trial Results

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

PHASE4INTERVENTIONAL La Mesa, California +4 more

RECRUITING

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

PHASE1INTERVENTIONAL Birmingham, Alabama +4 more

RECRUITING

Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases

PHASE2INTERVENTIONAL Philadelphia, Pennsylvania

RECRUITING

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

PHASE2INTERVENTIONAL Loma Linda, California +4 more

RECRUITING

VIBRANT: VIB4920 for Active Lupus Nephritis

PHASE2INTERVENTIONAL La Jolla, California +4 more

RECRUITING

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

PHASE2INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants

PHASE3INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

PHASE1, PHASE2INTERVENTIONAL Orange, California +4 more

RECRUITING

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

PHASE1INTERVENTIONAL Beverly Hills, California +4 more

RECRUITING

CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

PHASE1, PHASE2INTERVENTIONAL Philadelphia, Pennsylvania

RECRUITING

A Study of Quinacrine in Participants With Cutaneous Lupus Erythematosus

PHASE2INTERVENTIONAL Philadelphia, Pennsylvania

RECRUITING

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

PHASE3INTERVENTIONAL Beverly Hills, California +4 more

RECRUITING

Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus

N/AOBSERVATIONAL Philadelphia, Pennsylvania +1 more

RECRUITING

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

N/AOBSERVATIONAL La Jolla, California +4 more

RECRUITING

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

PHASE2INTERVENTIONAL Chicago, Illinois +3 more

RECRUITING

Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study

NAINTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

PHASE1INTERVENTIONAL Phoenix, Arizona +4 more

RECRUITING